Literature DB >> 26590173

Targeting BAFF/BLyS in lupus: is the glass half-full or half-empty?

Frédéric A Houssiau1, Andrea Doria2.   

Abstract

Entities:  

Keywords:  B cells; Systemic Lupus Erythematosus; Treatment

Mesh：

Substances：

Year:  2015        PMID： 26590173     DOI： 10.1136/annrheumdis-2015-208312

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

Review 1.  Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Authors:  Larosa Maddalena; Francesca Trentin; Mariele Gatto; Margherita Zen; Linda Nalotto; Francesca Saccon; Elisabetta Zanatta; Luca Iaccarino; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 2.  B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools.

Authors:  Ioannis Parodis; Mariele Gatto; Christopher Sjöwall
Journal:  Front Med (Lausanne)       Date:  2022-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.